https://health.economictimes.indiatimes.com/news/pharma/glenmark-launches-akynzeo-i-v-for-preventing-chemotherapy-induced-nausea/97241967
Glenmark Pharmaceuticals Ltd: Glenmark launches AKYNZEO I.V. for preventing chemotherapy induced...
Glenmark Pharmaceuticals Ltd: AKYNZEO I.V. is a fixed dose combination of fosnetupitant (235 mg) and palonosetron (0.25 mg), and is available as a...
glenmark pharmaceuticals ltdlaunches
https://health.economictimes.indiatimes.com/news/industry/glenmark-pharma-signs-rohit-sharma-as-brand-ambassador/81343275
Glenmark Pharmaceuticals Ltd.: Glenmark Pharma signs Rohit Sharma as brand ambassador, ETHealthworld
Glenmark Pharmaceuticals Ltd.: Rohit Sharma has "officially signed on to represent Glenmark's Candid Powder, a legacy brand of the company's consumer care...
glenmark pharmaceuticals ltdrohit sharmaas brandsigns
https://www.business-standard.com/markets/capital-market-news/glenmark-pharmaceuticals-ltd-eases-for-fifth-straight-session-124111800529_1.html
Glenmark Pharmaceuticals Ltd eases for fifth straight session | Capital Market News - Business...
Glenmark Pharmaceuticals Ltd is quoting at Rs 1526.05, down 0.5% on the day as on 13:19 IST on the NSE. The stock jumped 94.35% in last one year as compared to...
glenmark pharmaceuticals ltdcapital market news
https://health.economictimes.indiatimes.com/news/pharma/financial-performance/indias-glenmark-pharma-q1-profit-drops-on-higher-expenses/102670368
Glenmark Pharmaceuticals Ltd: India's Glenmark Pharma Q1 profit drops on higher expenses,...
Glenmark Pharmaceuticals Ltd: Consolidated net profit fell to 1.50 billion rupees ($18.12 million) for the three months ended June 30, from 1.93 billion rupees...
glenmark pharmaceuticals ltd